iBio, Inc. Files 8-K Report
Ticker: IBIO · Form: 8-K · Filed: Apr 8, 2025 · CIK: 1420720
| Field | Detail |
|---|---|
| Company | Ibio, Inc. (IBIO) |
| Form Type | 8-K |
| Filed Date | Apr 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulatory-disclosure
Related Tickers: IBIO
TL;DR
iBio filed an 8-K, mostly standard updates and exhibits.
AI Summary
On April 8, 2025, iBio, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation FD disclosure. No specific new material events or financial figures were detailed in the provided excerpt.
Why It Matters
This 8-K filing indicates that iBio, Inc. is providing updates or disclosures to the SEC, which could contain important information for investors regarding the company's operations or financial status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate indication of significant negative or positive events.
Key Players & Entities
- iBio, Inc. (company) — Registrant
- April 8, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-35023 (identifier) — Commission File Number
- 26-2797813 (identifier) — IRS Employer Identification No.
- 11750 Sorrento Valley Road, Suite 200 San Diego, California 92121 (address) — Principal executive offices
- ( 979 ) 446-0027 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by iBio, Inc.?
The filing is a Current Report on Form 8-K, reporting on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits as of April 8, 2025.
When was this 8-K report filed by iBio, Inc.?
The report was filed as of April 8, 2025.
What is iBio, Inc.'s state of incorporation?
iBio, Inc. is incorporated in Delaware.
What is the principal executive office address for iBio, Inc.?
The principal executive offices are located at 11750 Sorrento Valley Road, Suite 200, San Diego, California 92121.
Does the filing mention any specific new business developments or financial results?
The provided excerpt of the 8-K filing does not detail specific new business developments or financial results, focusing on the report's nature and company identification.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2025 regarding iBio, Inc. (IBIO).